View in EDS HTML Full Text PDF Full Text

Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of KCa3.1 K+ Channel Targeting In Vitro Are Dependent on Glioma Cell Line and Stem Cell Fraction.

Saved in:
Bibliographic Details
Title: Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of KCa3.1 K+ Channel Targeting In Vitro Are Dependent on Glioma Cell Line and Stem Cell Fraction.
Authors: Stransky N; Department of Radiation Oncology, University of Tübingen, 72076 Tübingen, Germany.; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, 72076 Tübingen, Germany., Ganser K; Department of Radiation Oncology, University of Tübingen, 72076 Tübingen, Germany., Naumann U; Molecular Neurooncology, Hertie Institute for Clinical Brain Research and Center Neurology, University of Tübingen, 72076 Tübingen, Germany., Huber SM; Department of Radiation Oncology, University of Tübingen, 72076 Tübingen, Germany., Ruth P; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, 72076 Tübingen, Germany.
Source: Cancers [Cancers (Basel)] 2022 Dec 15; Vol. 14 (24). Date of Electronic Publication: 2022 Dec 15.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36551685
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of K<subscript>Ca</subscript>3.1 K<superscript>+</superscript> Channel Targeting In Vitro Are Dependent on Glioma Cell Line and Stem Cell Fraction.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stransky+N%22">Stransky N</searchLink>; Department of Radiation Oncology, University of Tübingen, 72076 Tübingen, Germany.; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, 72076 Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Ganser+K%22">Ganser K</searchLink>; Department of Radiation Oncology, University of Tübingen, 72076 Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Naumann+U%22">Naumann U</searchLink>; Molecular Neurooncology, Hertie Institute for Clinical Brain Research and Center Neurology, University of Tübingen, 72076 Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Huber+SM%22">Huber SM</searchLink>; Department of Radiation Oncology, University of Tübingen, 72076 Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Ruth+P%22">Ruth P</searchLink>; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, 72076 Tübingen, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2022 Dec 15; Vol. 14 (24). <i>Date of Electronic Publication: </i>2022 Dec 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36551685
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers14246199
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of KCa3.1 K+ Channel Targeting In Vitro Are Dependent on Glioma Cell Line and Stem Cell Fraction.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stransky N
      – PersonEntity:
          Name:
            NameFull: Ganser K
      – PersonEntity:
          Name:
            NameFull: Naumann U
      – PersonEntity:
          Name:
            NameFull: Huber SM
      – PersonEntity:
          Name:
            NameFull: Ruth P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 12
              Text: 2022 Dec 15
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2072-6694
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 24
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1